| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |